Articles Posted in Talcum Powder and Cancer

Recently, the Department of Justice (DOJ) took a firm stand against giant pharmaceutical company Johnson & Johnson (J&J) after the company tried to file for bankruptcy again. Johnson & Johnson is facing mesothelioma and ovarian cancer lawsuits from tens of thousands of victims who blame the asbestos-contaminated talc in the company’s famous baby powder for their illness. To address these claims, J&J has repeatedly attempted a controversial strategy of filing for bankruptcy. Many people thought that J&J’s latest bankruptcy filing attempt would succeed. However, the DOJ intervened in the case and filed a motion to dismiss the company’s bankruptcy case.

Johnson & Johnson has followed in the footsteps of many asbestos companies facing lawsuits from mesothelioma and ovarian cancer victims. The pharmaceutical giant has filed for bankruptcy a number of times in an attempt to settle the tens of thousands of claims it is facing. All the claimants blame the company’s talc-based baby powder for their illness. They claim that the baby powder was contaminated with asbestos, a substance that is known to cause various illnesses, including mesothelioma and ovarian cancer. However, according to the U.S. Trustee, Johnson & Johnson is trying to abuse the bankruptcy system. The Trustee noted that J&J’s bankruptcy filing differs from standard asbestos trust funds since the company is not in need of bankruptcy relief. The Trustee noted that J&J is not in genuine financial distress.

Johnson & Johnson’s strategy involves filing for bankruptcy through a subsidiary called Red River Talc LLC. Pointing to this subsidiary, the U.S. Trustee said that it serves no legitimate purpose and seems solely designed to protect J&J, a company that is financially stable and cannot provide a conformable plan of reorganization. This is Johnson & Johnson’s third time attempting to file for Chapter 11 bankruptcy, a bankruptcy chapter that is meant for companies facing genuine financial distress. According to the Trustee, this third filing is no different from the previous filings that the court rejected for similar reasons.

Dynarex, a medical supply company based in New Jersey, recently recalled numerous cases of baby powder contaminated with asbestos. The baby powder had been sent to distributors in different states in the U.S., sparking fears over many people suffering asbestos exposure and eventually developing mesothelioma and other asbestos-related illnesses. The recall resulted from a routine U.S. Food and Drug Administration (FDA) sampling program, which revealed that the finished products were asbestos-contaminated. The FDA also identified other lots of products that contain asbestos because of the company’s use of the same bulk talc material.

The recall affects products that were distributed in Arkansas, Florida, Kentucky, New Jersey, Colorado, North Carolina, Alabama, Illinois, Washington, Tennessee, Wisconsin, Pennsylvania, and other states. In addition to being sold in stores, the affected products were also sold online through Amazon. According to the FDA, consumers who purchased Dynacare Baby Powder by Dynarex in several batches, including B048, B049, B050, B051, and B052, should not continue using the products.

Because of the growing concerns over asbestos contamination and the tens of thousands of lawsuits that have been filed against companies because of talc-based consumer products, many large companies have stopped using talc in their products. Studies have shown that long-term use of talc for personal care can increase the risk of asbestos-related diseases like mesothelioma and ovarian cancer. One of the most notable companies that stopped using talc in its products after facing significant legal liabilities for mesothelioma and ovarian cancer cases is Johnson & Johnson (J&J). With billions of dollars in damages awarded to claimants and countless cases yet to be filed and resolved, many companies have switched to using cornstarch as a safer alternative to talc in their consumer products. Despite this shift, Dynarex continued using talc in its products, putting consumers at risk.

The outcome of one of the nation’s first talcum powder/mesothelioma trials could determine if Johnson & Johnson agrees to another massive settlement.

The trial, taking place amidst J&J’s ongoing efforts to settle thousands of talc-related ovarian cancer lawsuits, involves a male plaintiff who alleges he developed mesothelioma due to inhaling asbestos allegedly present in Johnson’s Baby Powder.

Evan Plotkin argues he developed mesothelioma in 2021 at the age of 64 after years of using talc-based cosmetic products, however J&J, which denies its talc products ever contained asbestos, maintains his mesothelioma likely did not develop from asbestos exposure but rather from a family medical history that supposedly made him more likely to get cancer.

For purposes of this article, the deceased mesothelioma victim in this case will be referred to as T.G.

In a recent court decision, a Chicago appeals court upheld a jury’s verdict against Johnson & Johnson (J&J), providing the deceased mesothelioma victim’s family with the deserved justice. Earlier this year, a Cook County court in Illinois ordered the giant pharmaceutical company to pay T.G.’s family $45 million in damages after T.G. died of malignant mesothelioma. J&J tried to secure a retrial, but the court of appeals stood firm and ensured the jury’s decision in favor of the late T.G.’s family remained intact.

T.G., who had six children, was diagnosed with malignant mesothelioma, a rare and aggressive form of cancer that occurs due to asbestos exposure. This illness most commonly affects the lining of the lungs. After T.G.’s death, her family filed a wrongful death lawsuit against J&J. According to the lawsuit, the source of the asbestos exposure that resulted in the death of T.G. was J&J’s talc-based product, which she used throughout her life. T.G. also used the product on her children. During the trial, the family’s legal representative presented evidence revealing that J&J’s talc-based product contained asbestos and the company knew about the dangers of this for years but failed to inform or warn the public, thus endangering the lives of millions of consumers, including T.G. and her children.

A significant legal victory was recently achieved when a federal judge dismissed a lawsuit filed by Johnson & Johnson (J&J) against a mesothelioma researcher. For long, mesothelioma victims have encountered challenges when trying to hold companies liable for their asbestos exposure. Many asbestos companies have defended themselves by challenging scientific evidence. Often, these companies argue that there is no conclusive proof that asbestos exposure causes mesothelioma. They focus on the methods and data and refuse to accept responsibility. Most recently, J&J filed a lawsuit against a mesothelioma scientist whose research suggests that talc-based consumer products can cause cancer. However, the judge dismissed the giant pharmaceutical company’s suit, emphasizing the researcher’s right to free speech. The judge also found no evidence to show that the researcher’s findings were false.

J&J has faced tens of thousands of lawsuits filed by victims of mesothelioma and ovarian cancer who used the company’s talc-based baby powder. The victims blame the talc-based baby powder for their asbestos exposure, which, in turn, caused their illnesses. The claimants argue that J&J failed to adequately warn consumers about the potential dangers associated with their product. In response to the lawsuits against them, J&J has employed several strategies, including creating a subsidiary, LLT Management, that proceeded to file for bankruptcy. The company has also filed lawsuits against researchers, including one prominent mesothelioma researcher, Dr. Jacqueline Moline.

Plaintiffs have presented internal J&J documents describing fears over the company’s talc’s connection to cancer. Despite this, the company still filed lawsuits against several researchers. Johnson & Johnson has not only attacked the researchers’ studies but has also accused one of the researchers, Dr. Jacqueline Moline, of libel, fraud, and false advertising in connection to the paper she published that connects asbestos-containing talcum powder products to mesothelioma.

The giant pharmaceutical company Johnson & Johnson (J&J) is facing thousands of personal injury claims from people who blame the company’s talc products for ovarian cancer and malignant mesothelioma. After previously filing two bankruptcy claims and both claims being rejected by victims and courts, J&J recently made another attempt to file for Chapter 11 bankruptcy. The company hopes that the latest bankruptcy filing, which proposes a $10 billion compensation plan for victims and their families, will end litigation against it. So far, this third bankruptcy filing has received a vote of confidence from many victims.

When companies are hit with thousands of lawsuits alleging harm from their products, they face the risk of multi-million or even billion-dollar verdicts. Over the years, several ovarian cancer and mesothelioma victims who blame J&J’s talc-based products for their illnesses have been awarded multi-million dollar verdicts. Such financial judgments can be overwhelming. These substantial verdicts were the reason J&J pursued bankruptcy twice before. Bankruptcy provides a way for companies to manage and limit their financial exposure. By filing a Chapter 11 bankruptcy, also called reorganization bankruptcy, a company can propose a restructured plan to compensate victims and their families without having to pay out huge, unpredictable verdicts that could cripple the business financially. After a company files for Chapter 11 bankruptcy, the “automatic stay” halts ongoing litigation and prevents people from filing new cases. In the case of J&J, this third bankruptcy filing has stopped thousands of lawsuits from moving forward. If the bankruptcy is approved, the company can implement its proposed compensation plan.

Johnson & Johnson filed its first bankruptcy case in Charlotte, North Carolina, and the second case in Trenton, New Jersey. Both efforts were unsuccessful, as victims and courts rejected both cases. The third time, J&J filed its Chapter 11 bankruptcy case in Houston, Texas, immediately halting thousands of pending lawsuits. While J&J’s latest bankruptcy filing has garnered support from many victims with pending claims, the company still faces opposition from some victims and their attorneys, who are seeking higher compensation and more accountability from the pharmaceutical company.

For purposes of this article, the mesothelioma victim in this case will be referred to as Mr. E.P.

A recent mesothelioma lawsuit in Connecticut has attracted significant attention and highlighted concerns over previously unknown dangers of talcum powder in consumer products, notably Johnson & Johnson’s (J&J’s) talcum powder products. In this case, a 64-year-old man is blaming J&J’s talcum powder products for his mesothelioma. E.P. claims that illness resulted from prolonged use of the giant pharmaceutical company’s talcum powder. The personal injury lawsuit filed in Bridgeport Judicial District Court is part of a growing number of legal actions against J&J. The company has faced numerous lawsuits related to its talc-based products.

Mr. E.P.’s lawsuit centers on his prolonged use of Johnson & Johnson’s talcum powder. Mr. E.P. claims that his mesothelioma diagnosis was a result of using J&J’s talcum powder products to soothe rashes he suffered from as a child due to his weight. In his lawsuit, E.P. said he continued using the product in his youth since he was an athlete. According to the lawsuit, the giant pharmaceutical company failed in its duty to warn consumers about the health risks associated with its talcum powder, which is alleged to contain asbestos.

For purposes of this article, the mesothelioma victim in this case will be referred to as L.G.

In a recent court decision, the Supreme Court of New York rejected a talc supplier’s motion for summary judgment. This case centers around a woman who we will refer to as L.G. in this article. L.G. was diagnosed with malignant mesothelioma after years of using talc powder products. Kolmar Laboratories, the manufacturer of the products, was named as one of the defendants in L.G.’s negligence claim. Kolmar Laboratories petitioned for removal from the lawsuit, but the company’s arguments failed. The case will move forward for a jury to weigh the evidence.

After L.G. was diagnosed with malignant mesothelioma, she traced the cause of her illness to the Johnson & Johnson talc powder products she had used for many years. Malignant mesothelioma is a form of cancer that affects the thin tissue lining most internal organs, known as the mesothelium. Mesothelioma is a rare form of cancer. In the United States, around 3,000 new mesothelioma cases are diagnosed yearly. This illness is primarily caused by asbestos exposure. Asbestos is a naturally occurring mineral whose fibers are strong and heat resistant. This made asbestos useful in a wide variety of applications. When asbestos is disturbed, tiny fibers are released into the air, which can get stuck in the mesothelium after being inhaled or ingested. Over time, a person may suffer inflammation and scarring, leading to the development of malignant mesothelioma. Kolmar Laboratories manufactured the Johnson & Johnson products that L.G. used. Because of this, Kolmar was named as one of the defendants in L.G.’s mesothelioma claim.

A significant legal victory was recently achieved when a federal judge dismissed a lawsuit filed by Johnson & Johnson (J&J) against a mesothelioma researcher. For long, mesothelioma victims have encountered challenges when trying to hold companies liable for their asbestos exposure. Many asbestos companies have defended themselves by challenging scientific evidence. Often, these companies argue that there is no conclusive proof that asbestos exposure causes mesothelioma. They focus on the methods and data and refuse to accept responsibility. Most recently, J&J filed a lawsuit against a mesothelioma scientist whose research suggests that talc-based consumer products can cause cancer. However, the judge dismissed the giant pharmaceutical company’s suit, emphasizing the researcher’s right to free speech. The judge also found no evidence to show that the researcher’s findings were false.

J&J has faced tens of thousands of lawsuits filed by victims of mesothelioma and ovarian cancer who used the company’s talc-based baby powder. The victims blame the talc-based baby powder for their asbestos exposure, which, in turn, caused their illnesses. The claimants argue that J&J failed to adequately warn consumers about the potential dangers associated with their product. In response to the lawsuits against them, J&J has employed several strategies, including creating a subsidiary, LLT Management, that proceeded to file for bankruptcy. The company has also filed lawsuits against researchers, including one prominent mesothelioma researcher, Dr. Jacqueline Moline.

Plaintiffs have presented internal J&J documents describing fears over the company’s talc’s connection to cancer. Despite this, the company still filed lawsuits against several researchers. Johnson & Johnson has not only attacked the researchers’ studies but has also accused one of the researchers, Dr. Jacqueline Moline, of libel, fraud, and false advertising in connection to the paper she published that connects asbestos-containing talcum powder products to mesothelioma.

For purposes of this article, the mesothelioma victim in this case will be referred to as M.P.

In a recent court decision, a South Carolina state court jury awarded $63.4 million to a man diagnosed with malignant mesothelioma in a case against Johnson & Johnson (J&J). The compensation amount is meant to cover both punitive and compensatory damages. M.P. was diagnosed with malignant mesothelioma, a rare and aggressive illness that develops after asbestos exposure, at the age of 53. He blamed his illness on his lifelong use of Johnson & Johnson’s talc powder.

Malignant mesothelioma is a type of cancer that is rare in the United States. Statistics suggest that about 3,000 new mesothelioma cases are diagnosed in the United States annually. Mesothelioma develops after a person is exposed to asbestos. However, this illness does not develop immediately after exposure. It can take decades for mesothelioma to develop after asbestos exposure. Asbestos is a naturally occurring mineral that is resistant to heat, fire, and many chemicals. This made asbestos useful in many industries and products. However, when asbestos is disturbed, it releases fibers into the air, which, when inhaled or ingested, can become lodged in the lungs or other tissues, leading to serious health issues like mesothelioma.

Contact Information